Examkin

Soru

Zorluk: ZorCardiovascular System

During a winter evening shift in the emergency department, a 68-year-old retired teacher arrives complaining of progressively worsening breathlessness over the last 48 hours. She has a history of tobacco use (40 pack-years) and essential hypertension. The patient notes a persistent cough that worsens significantly when she attempts to sleep flat. Vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 162/95 mmHg, pulse of 108/min, and respirations of 26/min. Pulse oximetry reveals an oxygen saturation of 89% on room air. Physical examination demonstrates an elevated jugular venous pressure of 10 cm H2O above the sternal angle. Auscultation of the chest reveals diffuse, high-pitched expiratory wheezing throughout all lung fields without focal crackles. Cardiac auscultation shows a regular tachycardia with an audible third heart sound (S3) at the apex. Trace bilateral pitting edema is present at the ankles. Which of the following is the most appropriate initial pharmacotherapy for this patient's current condition?

  1. Intravenous furosemideCevap
  2. B
    Nebulized albuterol and ipratropium
  3. C
    Oral prednisone
  4. D
    Intravenous levofloxacin
  5. E
    Intravenous metoprolol

Cevap

Intravenous furosemide
The correct therapy is intravenous furosemide. This patient's clinical presentation—progressive dyspnea, pronounced orthopnea, elevated jugular venous pressure, and an S3 gallop—strongly indicates acute decompensated heart failure (ADHF). In ADHF, fluid accumulation around the bronchioles can cause airway narrowing and diffuse wheezing, a phenomenon classically referred to as 'cardiac asthma.' Despite her extensive smoking history, which heavily increases her risk for COPD, the distinct cardiovascular physical exam findings (specifically the elevated JVP and S3 gallop) point definitively to a primary cardiac etiology for her acute respiratory distress. The most appropriate initial pharmacotherapy for ADHF with volume overload is an intravenous loop diuretic. This intervention rapidly decreases preload, relieves pulmonary congestion, and subsequently resolves the secondary wheezing.

Adım Adım Çözüm

1
Analyze the patient's demographic risk factors, presenting symptoms, and vital signs.
The patient is a heavy smoker presenting with dyspnea, orthopnea, hypoxia, and tachycardia in the winter.
To establish the acuity of the respiratory distress and identify competing diagnostic hypotheses (e.g., COPD exacerbation vs. Heart Failure).
2
Evaluate the specific physical examination findings to differentiate the etiology.
Elevated jugular venous pressure (JVP), an S3 gallop, and diffuse wheezing are identified.
Cardiac findings are crucial to separate cardiogenic dyspnea from primary pulmonary disease.
3
Synthesize the findings to confirm the primary diagnosis.
The presence of an S3 gallop, elevated JVP, and prominent orthopnea definitively points to acute decompensated heart failure (ADHF). The wheezing represents 'cardiac asthma' caused by peribronchial edema.
A COPD exacerbation alone would not produce an S3 gallop or acute left-sided volume overload signs like profound orthopnea and elevated JVP.
4
Select the most appropriate initial management step based on the diagnosis.
Intravenous loop diuretics are indicated to reduce intravascular volume.
Diuresis rapidly decreases central venous pressure and pulmonary capillary wedge pressure, relieving the pulmonary edema and subsequent wheezing.

Anahtar Kavram

Differentiating acute decompensated heart failure (cardiac asthma) from COPD exacerbation using cardiovascular physical exam findings (S3 gallop, elevated JVP) to guide appropriate diuretic therapy.
Bu soruyu puanla

Konular

Cardiovascular System

Bu konudan daha fazla soru